# ACETAMINOPHEN AND IBUPROFEN
> **ANDA216994** · Abbreviated New Drug Application (Generic) · Sponsor: MARKSANS PHARMA · Approved 2023-07-10
## Drug
- **FDA Application Number:** ANDA216994
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ACETAMINOPHEN AND IBUPROFEN
- **Generic name:** ACETAMINOPHEN, IBUPROFEN
- **Active ingredients:** ACETAMINOPHEN; IBUPROFEN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** MARKSANS PHARMA
- **Manufacturer:** BETTER LIVING BRANDS, LLC
- **First approval:** 2023-07-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216994)
---
*MORVS · CC0 1.0*